(NASDAQ:AIHS), CHENGDU, China, Nov. 20, 2025 (GLOBE NEWSWIRE) — Senmiao Technology Limited (NASDAQ: AIHS) (“Senmiao” or the “Company”), today announced the closing of its registered direct offering (the “Offering”). The Company has sold 1,350,000 shares (the “Shares”) of common stock and pre-funded warrants to purchase 905,000 shares of common stock at a purchase price of […]

(NasdaqGM:RXST), ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City. RxSight's management

(NASDAQ:NCSM), HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) announced today that Ryan Hummer, Chief Executive Officer, is scheduled to present at the Sidoti Year End Virtual Conference on Wednesday, December 10, 2025, at 12:45 p.m. Central Time (1:45 p.m. Eastern Time). To attend the presentation, interested

(CNSX:BOIL.CN),(OTC US:BEOLF),(Other OTC:BEOLF),(Boerse Frankfurt – Freiverkehr:UH9),(Boerse Frankfurt – Freiverkehr:UH9.F),(TSX:BOIL), VANCOUVER, British Columbia and KIBBUTZ YIFAT, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — Beyond Oil Ltd. (TSX: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) (“Beyond Oil” or the “Company”), a food-tech innovation company dedicated to reducing health risks associated with fried food while lowering operational costs, minimizing waste

(NASDAQ:DRTS),(NASDAQ:DRTSW), – Alpha DaRT pancreatic cancer patient treatments underway in U.S. multi-center pilot study – – Newly received radioactive material license for New Hampshire facility positions the Company for continued advancement towards commercial readiness – – Multiple meaningful milestones targeted in the coming months, including completion of patient recruitment in the U.S. pivotal ReSTART trial

(NASDAQ:MDBH), Addison, TX, Nov. 20, 2025 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended September 30, 2025, and subsequent developments. Third Quarter 2025 and Subsequent Operational Highlights Anticipate closing two offerings shortly: This

(NASDAQ:CRNX), CAREFNDR underscores the potential clinical value of paltusotine beyond acromegaly, and demonstrates progress in Crinetics' commitment to addressing unmet needs in the neuroendocrine tumor community SAN DIEGO, Nov. 20, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the first patient has been randomized in the pivotal Phase 3 CAREFNDR trial, a

(NASDAQ:MDGL), CONSHOHOCKEN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on November 15, 2025 to three new non-executive employees as equity inducement awards under the terms of Madrigal's 2025 Inducement Plan. The

(NASDAQ:ZUMZ), LYNNWOOD, Wash., Nov. 20, 2025 (GLOBE NEWSWIRE) — Zumiez Inc. (NASDAQ: ZUMZ) today announced it will report fiscal 2025 third quarter results on Thursday, December 4, 2025, following the closing of regular stock market trading hours. The Company will hold a conference call that day at 5:00 p.m. ET to review the results. To

(NASDAQ:LPLA), SAN DIEGO, Nov. 20, 2025 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), today released its monthly activity report for October 2025. Total advisory and brokerage assets at the end of October were $2.35 trillion, an increase of $36.6 billion, or 1.6%, compared to the end of September 2025. Total organic